CELG DMA
As of date:11/20/2019
CELG stock price:108.24
CELG 50 DMA:103.23
CELG 200 DMA:95.60
CELG MACD (200-50):-7.63

Also see:
CELG Market Cap History
CELG Shares Outstanding History
CELG YTD Return
CELG RSI
CELG MACD
CELG Technical Analysis

GWG Holdings Shares Cross Above 200 DMA
1 hour, 11 minutes ago


Bullish Two Hundred Day Moving Average Cross - PRTA
1 hour, 11 minutes ago


AVAV Crosses Above Key Moving Average Level
1 hour, 16 minutes ago


Bullish Two Hundred Day Moving Average Cross - CWCO
1 hour, 20 minutes ago


Studio City International Holdings Breaks Above 200-Day Moving Average - Bullish for MSC
1 hour, 21 minutes ago


LHC Crosses Above Key Moving Average Level
1 hour, 30 minutes ago


Zymeworks (ZYME) Shares Cross Above 200 DMA
1 hour, 31 minutes ago


VEEV Crosses Above Key Moving Average Level
1 hour, 31 minutes ago


Ares Management Breaks Above 200-Day Moving Average - Bullish for ARES
1 hour, 31 minutes ago


Shares of MTL Now Oversold
1 hour, 42 minutes ago


CIEN Crosses Above Key Moving Average Level
1 hour, 42 minutes ago


REM Crowded With Sellers
1 hour, 46 minutes ago


Shares of NEXA Now Oversold
6 hours, 7 minutes ago


TALO Crosses Critical Technical Indicator
6 hours, 19 minutes ago


DNOW Crosses Critical Technical Indicator
6 hours, 19 minutes ago


More Technical Analysis News

CELG DMACELG MACD
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co.'s products are sold worldwide, primarily to wholesalers, specialty distributors, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the United States and Puerto Rico and has manufacturing operations in two foreign countries. Co. has products in the following therapeutic classes: hematology, oncology, cardiovascular and immunology. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics.

When researching a stock like Celgene, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from CELG Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for CELG stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the CELG 200 day moving average ("CELG 200 DMA"), while one of the most popular "shorter look-backs" is the CELG 50 day moving average ("CELG 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Celgene.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for CELG:
CELG SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celgene (CELG) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

CNC DMA
COO DMA
DGX DMA
DHR DMA
DVA DMA
EW DMA
GILD DMA
HCA DMA
HOLX DMA
HSIC DMA
More Healthcare companies »

 

CELG DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.